Send Enquiry

VENTILA
Respules
Packaging and packing Type
| 4x5x2.5ml
MRP :
₹380
PTR :
₹289.52
PTS :
₹260.57
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Respiratory PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Iptrovib Respules are respules for inhalation with a nebuliser, made by Vibcare Pharma and available from the company's Prima division. Each respule contains Levosalbutamol 1.25 mg and Ipratropium Bromide 500 mcg. It belongs to the Respiratory and Anti-Asthmatic class of medicines and is packed as 4x5x2.5ml.
Levosalbutamol is a beta-2 adrenergic agonist that relaxes the smooth muscle of the airways, from the trachea to the small bronchioles, and helps the air passages remain open. Ipratropium Bromide is an anticholinergic that blocks the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle and stops the airways from tightening. The two actions together support easier airflow through the lungs.
These respules are used to treat or prevent bronchospasm in patients with reversible obstructive airway disease and for relief of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Iptrovib Respules is part of Vibcare Pharma's respiratory range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Iptrovib Respules: Levosalbutamol 1.25 mg and Ipratropium Bromide 500 mcg for inhalation, used for bronchospasm in obstructive airway disease. Main uses: treatment or prevention of bronchospasm in patients with reversible obstructive airway disease; relief of bronchospasm associated with chronic obstructive pulmonary disease (COPD); maintenance relief of airflow obstruction in chronic bronchitis; maintenance relief of airflow obstruction in emphysema.
Common side effects of Iptrovib Respules include palpitations; headache; dizziness; tremor; nervousness; dry mouth. Get medical help at once if you notice paradoxical bronchospasm (sudden worsening of breathing after use; stop and contact a doctor immediately); chest pain or rapid heart rate; low potassium in the blood (hypokalemia).
Iptrovib Respules contains Levosalbutamol 1.25 mg + Ipratropium Bromide 500 mcg. The right dose and how long to take it depend on the condition, age and other medicines, so use Iptrovib Respules only as your doctor advises.
The MRP of Iptrovib Respules is ₹380 for a pack of 4x5x2.5ml. For chemists and distributors, the PTR is ₹289.52 and the PTS is ₹260.57.
Iptrovib Respules contains Levosalbutamol 1.25 mg + Ipratropium Bromide 500 mcg. It comes in a pack of 4x5x2.5ml.
Levosalbutamol is a beta-2 adrenergic agonist that relaxes the smooth muscle of the airways, from the trachea to the small bronchioles, and helps the air passages remain open. Ipratropium Bromide is an anticholinergic that blocks the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle and stops the airways from tightening. The two actions together support easier airflow through the lungs.
Must not be used by patients with a known allergy to levalbuterol, salbutamol (racemic albuterol), ipratropium bromide or any other ingredient of the respule. Must not be used by patients with a known allergy to atropine or any of its derivatives. Check with a doctor first if you have an underlying heart or cardiovascular condition. Check with a doctor first if you have narrow-angle glaucoma, prostate enlargement or bladder-neck obstruction. Check with a doctor first if you are pregnant or breastfeeding.
Iptrovib Respules is a brand of Vibcare Pharma, sold through its Ventila division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner